风湿性关节炎中的心血管风险:评估和管理方面的考虑
Panagiota Anyfanti1, Alexandra Ainatzoglou2, Elena Angeloudi1
1Second Medical Department, Hippokration Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece.
Mediterranean journal of rheumatology
|October 28, 2024
概括
患有类风湿性关节炎 (RA) 的患者面临心血管疾病 (CVD) 风险的两倍. 管理这种情况需要综合照顾和精确的风险评估,超出一般人群工具.
科学领域:
- 类风湿病学 类风湿病学
- 心脏病学 心脏病学
- 公共卫生 公共卫生
背景情况:
- 类风湿性关节炎 (RA) 显著增加心血管疾病 (CVD) 风险,导致预后不佳和死亡率.
- 慢性炎症,生活方式因素和RA患者药物副作用加剧了心血管疾病的发展.
- 目前的心血管疾病风险计算器在RA患者中缺乏优异的准确性,与一般人群相比.
研究的目的:
- 对风湿性关节炎患者的当前心血管风险评估和管理策略进行审查.
- 强调在RA护理中需要个性化,以指导方针为导向的干预措施.
- 突出一个多学科联盟的重要性,以指导心血管疾病风险管理在RA.
主要方法:
- 关于RA中心血管疾病风险的现有文献的叙述性综述.
- 分析当前CVD风险评估工具及其在RA中的局限性.
- 讨论管理策略和综合医疗保健的作用.
主要成果:
- 在RA患者中,心血管疾病的发病率是RA患者的两倍多.
- 现有的风险评估工具在准确预测RA中的心血管疾病方面存在局限性.
- 基于指导方针的个性化干预措施对于管理RA中心血管疾病风险至关重要.
结论:
- 有效的心血管风险管理对于改善RA患者的治疗结果至关重要.
- 需要涉及各种医疗保健提供者的协作方法,以便在RA中进行最佳的CVD风险评估和管理.
- 需要进一步的研究和综合护理模型来解决RA中心血管疾病负担的增加.
相关概念视频
01:20Rheumatic Heart Disease IV: Nursing Management
5
AssessmentA comprehensive assessment is essential in managing a patient with rheumatic heart disease (RHD). Begin with obtaining a detailed medical history, including recent streptococcal infections, a history of rheumatic fever, or previously diagnosed rheumatic heart disease. Assess the patient for symptoms such as fever, chest pain, widespread joint pain (arthralgia), tachycardia, pericardial friction rub, muffled heart sounds, heart murmurs, peripheral edema, subcutaneous nodules, and...
5
01:21Rheumatic Heart Disease III: Medical Management
3
Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
3
01:22Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
7
The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
7
01:23Rheumatic Heart Disease I: Introduction
3
Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
3
01:23Atherosclerosis IV: Nursing Management
1
Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...
1
01:26Atherosclerosis III: Management
1
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
1